Leishmania major n-myristoyltransferase in complex with a quinoline inhibitor (compound 26). Deposition Author(s): Bell, A.S. , Brannigan, J.A. , Goncalves, V. , Laporte, A. , Leatherbarrow, R.J. , Roberts, S.M. , Tate, E.W. , Wilkinson, A.J.
Date: 2016-04-06 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Leishmania Major Sequences Data: 5G21_A
Plasmodium vivax n-myristoyltransferase in complex with a quinoline inhibitor (compound 26) Deposition Author(s): Bell, A.S. , Brannigan, J.A. , Goncalves, V. , Laporte, A. , Leatherbarrow, R.J. , Roberts, S.M. , Tate, E.W. , Wilkinson, A.J.
Date: 2016-04-06 Method: X-RAY DIFFRACTION Resolution: 2.32 Å Organism(s): Plasmodium Vivax Sequences Data: 5G22_A , 5G22_B , 5G22_C
Human n-myristoyltransferase (nmt1) with myristoyl-coa and imp-1088 inhibitor bound Deposition Author(s): Bell, A.S. , Perez-Dorado, I. , Tate, E.W.
Date: 2017-01-12 Method: X-RAY DIFFRACTION Resolution: 1.88 Å Organism(s): Homo Sapiens Sequences Data: 5MU6_A , 5MU6_B
Human n-myristoyltransferase 1 (mnt1) with myristoyl-coa analogue x10 bound Deposition Author(s): Fedoryshchak, R. , Perez-Dorado, I. , Shen, M. , Tate, E.W.
Date: 2017-04-18 Method: X-RAY DIFFRACTION Resolution: 2.372 Å Organism(s): Homo Sapiens Sequences Data: 5NPQ_A , 5NPQ_B
Human n-myristoyltransferase (nmt1) with myristoyl-coa and peptide bound Deposition Author(s): Perez-Dorado, I. , Ritzefeld, M. , Tate, E.W.
Date: 2017-09-13 Method: X-RAY DIFFRACTION Resolution: 2.1 Å Organism(s): Homo Sapiens Sequences Data: 6EHJ_A , 6EHJ_B
Coping with strong translational non-crystallographic symmetry and extreme anisotropy in molecular replacement with phaser: human rab27a Deposition Author(s): Cota, E. , Jamshidiha, M. , Murray, J.W. , Perez-Dorado, I. , Read, R.J. , Tate, E.W.
Date: 2018-10-08 Method: X-RAY DIFFRACTION Resolution: 2.82 Å Organism(s): Homo Sapiens Sequences Data: 6HUF_A , 6HUF_O , 6HUF_N , 6HUF_B , 6HUF_E , 6HUF_C , 6HUF_K , 6HUF_M , 6HUF_D , 6HUF_P , 6HUF_F , 6HUF_J , 6HUF_G , 6HUF_I , 6HUF_H , 6HUF_L
Crystal structure of the rab27a fusion with slp2a-rbda1 effector for sf4 pocket drug targeting Deposition Author(s): Cota, E. , De Vita, E. , Jamshidiha, M. , Lanyon-Hogg, T. , Morgan, R.M.L. , Perez-Dorado, I. , Sutherell, C.L. , Tate, E.W. , Tersa, M.
Date: 2021-06-01 Method: X-RAY DIFFRACTION Resolution: 2.32 Å Organism(s): Homo Sapiens Sequences Data: 7OPP_A , 7OPP_C
Rab27a fusion with slp2a-rbda1 effector covalent adduct with ca1 in c188 Deposition Author(s): Cota, E. , De Vita, E. , Jamshidiha, M. , Lanyon-Hogg, T. , Morgan, R.M.L. , Perez-Dorado, I. , Sutherell, C.L. , Tate, E.W. , Tersa, M.
Date: 2021-06-01 Method: X-RAY DIFFRACTION Resolution: 2.23 Å Organism(s): Homo Sapiens Sequences Data: 7OPQ_A , 7OPQ_B
Rab27a fusion with slp2a-rbda1 effector covalent adduct with cb1 in c123 Deposition Author(s): Cota, E. , De Vita, E. , Jamshidiha, M. , Lanyon-Hogg, T. , Morgan, R.M.L. , Perez-Dorado, I. , Sutherell, C.L. , Tate, E.W. , Tersa, M.
Date: 2021-06-01 Method: X-RAY DIFFRACTION Resolution: 2.32 Å Organism(s): Homo Sapiens Sequences Data: 7OPR_A , 7OPR_B
Crystal structure of klk6 in complex with compound 16a Deposition Author(s): De Vita, E. , Hennig, J. , Jagtap, P.K.A. , Tate, E.W. , Zhang, L.
Date: 2021-12-06 Method: X-RAY DIFFRACTION Resolution: 1.47 Å Organism(s): Homo Sapiens , Synthetic Construct Sequences Data: 7QFT_A , 7QFT_B , 7QFT_C , 7QFT_D